Philips to Halt Sales of CPAP Devices, Could Lose $400M

The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the US, under a tentative agreement with regulators that could cost it nearly $400 million. Device maker Philips has recalled more than 5 million pressurized breathing machines due to risks…#philips #dutch #fda #departmentofjustice #pennsylvania
Source: Reuters: Health - Category: Consumer Health News Source Type: news